‘Lost India’ to China? Trump goes into damage control mode, says nothing to worry about ties

After incendiary remarks strained ties with India, President Trump attempted damage control, affirming the “special relationship” despite disappointment over India’s Russian oil purchases, threatening a 50% tariff. This came after India rejected US demands, asserting its right to choose its oil sources. While some US officials adopted a confrontational stance, others signaled a desire to…

Read More

Bigg Boss 19: Farhana Bhatt and Kunickaa Sadanand get into a fight as Farhana calls her a ‘failed captain’

Bigg Boss 19 witnesses a major argument between Kunickaa Sadanand and Farhana Bhatt, reigniting their rivalry. Kunickaa taunts Farhana’s captaincy, leading Farhana to fiercely defend herself and question Kunickaa’s own past performance. The heated exchange escalates with shouting, as other housemates react and some attempt to de-escalate the situation.

Read More

Elon Musk hit by mass resignations: Why his CEO Linda Yaccarino and 14 other executives may have just quit

Linda Yaccarino’s departure as CEO of X highlights growing turmoil under Elon Musk, marked by high-profile exits across his ventures. Fourteen senior leaders from Tesla, SpaceX, and X have resigned in the past year, citing disagreements over strategy, political focus, and internal tensions. These departures raise concerns about Musk’s ability to retain top talent amidst…

Read More

Gold prices hit record highs: US shutdown, Fed rate cut bets boost demand; silver rallies too

Gold prices surged to unprecedented levels globally and domestically, driven by safe-haven demand amidst the US government shutdown and anticipated Federal Reserve rate cuts. MCX gold futures hit new records, with the February 2026 contract reaching Rs 1,20,845 per 10 grams. Silver also rallied significantly as investors sought safety, despite mixed physical demand.

Read More

IIT-Madras launches cancer genome and tissue bank; could provide breakthrough in Cancer treatment

IIT-Madras has initiated a revolutionary cancer genome and tissue bank, advancing personalized therapy in India. Scientists are testing therapies on cultured tumor samples, identifying Indian-specific mutations, and developing early detection markers. This effort, supported by the Bharat Cancer Genome Atlas, aims to deliver precise, affordable, and tailored cancer treatment.

Read More